NCT03709862

Brief Summary

Syphilis is an important sexually transmitted infection. There has been an epidemic of syphilis amongst men who have sex with men in the United Kingdom in the last decade. Early infection with syphilis causes a genital ulcer followed, in the absence of treatment, by a generalised illness often accompanied by rash. Studies on syphilis have been limited because it is not possible to grow syphilis outside of the body. New approaches allow the whole genetic sequence of Treponema pallidum to be obtained from a swab. In this study residual DNA collected as part of routine patient care of patients seen at sexual health clinics in the UK will be used for sequencing. No patient contact is involved in the study which is limited to whole genome sequencing using residual material from samples. By better understanding the genome of the T.pallidum insights will be gained in to the pathogenesis of this important sexually transmitted disease.

Trial Health

87
On Track

Trial Health Score

Automated assessment based on enrollment pace, timeline, and geographic reach

Enrollment
726

participants targeted

Target at P75+ for all trials

Timeline
Completed

Started Oct 2018

Typical duration for all trials

Geographic Reach
1 country

5 active sites

Status
completed

Health score is calculated from publicly available data and should be used for screening purposes only.

Trial Relationships

Click on a node to explore related trials.

Study Timeline

Key milestones and dates

First Submitted

Initial submission to the registry

October 8, 2018

Completed
Same day until next milestone

Study Start

First participant enrolled

October 8, 2018

Completed
9 days until next milestone

First Posted

Study publicly available on registry

October 17, 2018

Completed
2.2 years until next milestone

Primary Completion

Last participant's last visit for primary outcome

December 31, 2020

Completed
1.2 years until next milestone

Study Completion

Last participant's last visit for all outcomes

February 28, 2022

Completed
Last Updated

April 12, 2022

Status Verified

April 1, 2022

Enrollment Period

2.2 years

First QC Date

October 8, 2018

Last Update Submit

April 11, 2022

Conditions

Outcome Measures

Primary Outcomes (1)

  • Genomic Diversity of Treponema Pallidum as assessed by nucleotide diversity and phylogenetic lineage

    Whole genome sequencing of UK and global syphilis samples combined with phylogenomic and population genomic analyses to determine the population structure and diversity of Treponema both regionally and in global context. Diversity will be assessed by measuring nucleotide diversity between samples and reference genomes.

    Measured at baseline - time of enrollment. There are no further samples or visits in the study.

Study Arms (1)

Syphilis

Patients with syphilis and detectable Treponema pallidum DNA in a routinely collected clinical sample

Diagnostic Test: Whole Genome Sequencing

Interventions

Residual DNA from clinical samples will be utilised for whole genome sequencing of Treponema pallidum the causative agent of syphilis

Syphilis

Eligibility Criteria

Age18 Years+
Sexall
Healthy VolunteersNo
Age GroupsAdult (18-64), Older Adult (65+)
Sampling MethodNon-Probability Sample
Study Population

Patients presenting to sexual health services in UK with a diagnosis of syphilis. We will identify residual T.pallidum DNA from routinely collected clinical samples held at participating clinics/hospitals. Data accompanying these samples will be anonymised and will not include patient identifiable information. Accompanying data will include: city of origin, age, gender, HIV status and sexual orientation.

You may qualify if:

  • Diagnosis of syphilis

You may not qualify if:

  • No PCR positive clinical sample

Contact the study team to confirm eligibility.

Sponsors & Collaborators

Study Sites (5)

University Hospitals Birmingham

Birmingham, United Kingdom

Location

Brighton and Sussex NHS Trust

Brighton, United Kingdom

Location

Leeds University Teaching Hospital

Leeds, United Kingdom

Location

Mortimer Market Centre

London, United Kingdom

Location

Penine Acute Hospitals Trust

Manchester, United Kingdom

Location

Biospecimen

Retention: SAMPLES WITH DNA

Residual DNA from routine clinical samples (lesion swabs/serum) of patients with Syphilis

MeSH Terms

Conditions

Syphilis

Condition Hierarchy (Ancestors)

Treponemal InfectionsSpirochaetales InfectionsGram-Negative Bacterial InfectionsBacterial InfectionsBacterial Infections and MycosesInfectionsSexually Transmitted Diseases, BacterialSexually Transmitted DiseasesCommunicable DiseasesGenital DiseasesUrogenital Diseases

Study Design

Study Type
observational
Observational Model
CASE ONLY
Time Perspective
RETROSPECTIVE
Sponsor Type
OTHER
Responsible Party
SPONSOR

Study Record Dates

First Submitted

October 8, 2018

First Posted

October 17, 2018

Study Start

October 8, 2018

Primary Completion

December 31, 2020

Study Completion

February 28, 2022

Last Updated

April 12, 2022

Record last verified: 2022-04

Locations